Maria Gabriella Matera Selected Research

Expectorants (Mucolytics)

11/2020	Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent.
5/2019	Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.
1/2018	Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease.
10/2017	Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
1/2017	Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Gabriella Matera Research Topics

Disease

121	Chronic Obstructive Pulmonary Disease (COPD) 06/2022 - 01/2003
69	Asthma (Bronchial Asthma) 08/2022 - 01/2002
20	Inflammation (Inflammations) 07/2022 - 01/2004
8	Airway Obstruction (Choking) 01/2022 - 01/2002
8	COVID-19 01/2022 - 01/2020
8	Pneumonia (Pneumonitis) 01/2021 - 05/2004
7	Chronic Bronchitis 06/2022 - 10/2005
5	Cough 01/2021 - 01/2002
5	Heart Failure 01/2020 - 02/2010
4	Bronchiectasis 01/2022 - 01/2016
4	Infections 01/2021 - 01/2004
4	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2021 - 10/2017
4	Bronchial Spasm 06/2016 - 06/2013
3	Lung Diseases (Lung Disease) 11/2020 - 08/2018
3	Cystic Fibrosis (Mucoviscidosis) 10/2019 - 01/2016
3	Respiratory Tract Infections (Respiratory Tract Infection) 12/2018 - 01/2016
3	Chronic Cough 12/2017 - 07/2016
2	Respiratory Hypersensitivity 10/2021 - 10/2020
2	Bronchitis 12/2018 - 01/2016
2	Headache (Headaches) 01/2018 - 08/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2017 - 09/2010
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2017 - 08/2011
2	Dyspnea (Shortness of Breath) 05/2015 - 06/2013
2	Allergic Rhinitis 06/2014 - 06/2008
2	Bacterial Pneumonia 03/2005 - 05/2004
1	Eosinophilia 01/2022

Drug/Important Bio-Agent (IBA)

48	Bronchodilator Agents (Bronchodilators)IBA 06/2022 - 01/2003
39	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2022 - 10/2007
24	Muscarinic AntagonistsIBA 07/2022 - 02/2010
21	Pharmaceutical PreparationsIBA 01/2021 - 05/2005
16	Tiotropium Bromide (Spiriva)FDA Link 12/2021 - 01/2004
13	Cholinergic Agents (Cholinergics)IBA 01/2021 - 03/2014
11	Formoterol Fumarate (Oxis)FDA Link 12/2018 - 01/2003
10	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 10/2021 - 01/2014
10	indacaterolIBA 10/2021 - 07/2005
9	Biological ProductsIBA 07/2022 - 07/2016
9	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2022 - 10/2012
9	Acetylcysteine (Siran)FDA LinkGeneric 01/2021 - 03/2014
8	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2004
8	CytokinesIBA 01/2021 - 01/2004
8	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2020 - 01/2007
6	Monoclonal AntibodiesIBA 01/2021 - 04/2015
5	Biomarkers (Surrogate Marker)IBA 06/2022 - 10/2016
5	GSK573719IBA 03/2022 - 01/2013
5	vilanterolIBA 03/2022 - 01/2013
5	Interleukin-5 (Interleukin 5)IBA 01/2021 - 01/2018
5	Expectorants (Mucolytics)IBA 11/2020 - 01/2017
5	doxofyllineIBA 01/2020 - 01/2017
5	Theophylline (Theon)FDA LinkGeneric 01/2020 - 01/2017
4	Albuterol (Salbutamol)FDA LinkGeneric 01/2021 - 06/2013
4	erdosteineIBA 01/2021 - 01/2018
4	GoldIBA 07/2020 - 08/2015
4	reslizumabIBA 01/2019 - 09/2017
4	aclidinium bromideIBA 01/2017 - 04/2013
3	fluticasone furoate FDA Link 03/2022 - 02/2015
3	ChemokinesIBA 01/2021 - 09/2016
3	AntioxidantsIBA 01/2021 - 01/2017
3	SteroidsIBA 12/2020 - 08/2018
3	GlucocorticoidsIBA 12/2020 - 01/2014
3	benralizumabIBA 10/2020 - 09/2017
3	mepolizumabIBA 10/2020 - 09/2017
3	Therapeutic UsesIBA 01/2020 - 09/2016
3	AdiponectinIBA 01/2020 - 10/2016
3	ensifentrineIBA 10/2019 - 06/2015
3	RoflumilastIBA 01/2018 - 07/2016
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2017 - 01/2002
3	Phosphodiesterase 4 InhibitorsIBA 08/2016 - 11/2014
3	Cholinergic Antagonists (Anticholinergics)IBA 01/2016 - 09/2010
2	VaccinesIBA 10/2021 - 04/2021
2	Oxygen (Dioxygen)IBA 01/2021 - 09/2010
2	Sulfhydryl Compounds (Thiols)IBA 01/2021 - 11/2020
2	Adenosine Monophosphate (AMP)IBA 01/2021 - 07/2016
2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2021 - 01/2020
2	Phosphodiesterase InhibitorsIBA 01/2021 - 11/2014
2	Interleukin-13IBA 01/2021 - 04/2020
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2021 - 11/2018
2	tiotropium-olodaterolIBA 01/2020 - 12/2019
2	Beclomethasone (Beclometasone)FDA Link 12/2018 - 02/2011
2	LipopolysaccharidesIBA 07/2018 - 01/2017
2	Humanized Monoclonal AntibodiesIBA 04/2018 - 09/2017
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2018 - 01/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2017 - 10/2007
2	BromidesIBA 01/2017 - 01/2015
2	Oxidants (Oxidizing Agents)IBA 01/2017 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 12/2016 - 10/2012
2	Budesonide (Pulmicort)FDA LinkGeneric 10/2016 - 02/2011
2	PowdersIBA 06/2016 - 02/2015
2	Messenger RNA (mRNA)IBA 07/2015 - 01/2004
2	indacaterol-glycopyrronium combinationIBA 05/2015 - 01/2015
2	olodaterolIBA 01/2015 - 01/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2010 - 05/2004
2	EndotoxinsIBA 03/2005 - 05/2004
2	Immunologic Adjuvants (Immunologic Adjuvant)IBA 03/2005 - 05/2004

Therapy/Procedure

70	Therapeutics 08/2022 - 01/2002
12	Nebulizers and Vaporizers (Inhaler) 08/2022 - 03/2004
3	Drug Therapy (Chemotherapy) 07/2022 - 01/2017
3	Biological Therapy 07/2022 - 01/2018
3	Precision Medicine 01/2018 - 01/2017
2	Duration of Therapy 12/2020 - 01/2017
1	Respiratory Therapy (Therapy, Respiratory) 01/2022